Elevance health announces closing of bioplus acquisition

Indianapolis--(business wire)--elevance health (nyse: elv) today announced the closing of its acquisition of bioplus, a comprehensive specialty pharmacy subsidiary of carepathrx, a portfolio company of nautic partners. bioplus provides a complete range of specialty pharmacy services for patients living with complex and chronic conditions, such as cancer, multiple sclerosis, hepatitis c, autoimmune diseases, and rheumatology.
ELV Ratings Summary
ELV Quant Ranking